The FDA's decision on a chatbot for patients recovering from surgery could offer clues on how the agency plans to regulate ...

Forty-Hz auditory stimulation increased amyloid clearance markers in aged primates and produced lasting effects, supporting its potential as a non-invasive Alzheimer’s therapy. Scientists at the Kunmi ...

Chinese scientists have developed a new EV battery capable of delivering over 1,000 km (620 miles) of driving range ...

New drug could reverse effects of sepsis, rather than trying to treat infection with antibiotics ...

A new leak points to a major Apple breakthrough in foldable screens: The crease will be almost imperceptible, and production has already advanced to the official order stage.

Where FDA breakthrough devices stand through 2025: growth, authorizations, leading specialties, AI trends, and qualification pathways explained.

A team in China has demonstrated the simultaneous teleportation of multiple sideband qumodes in a continuous-variable system, overcoming a longstanding technical barrier.

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

Luvesilocin is a subcutaneously-administered, proprietary prodrug of the psilocybin-like compound 4-OH-DiPT designed to target the serotonin 2A receptor.

Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR ...

The research reveals something fundamental about cancer. It’s not a sudden event that instantly produces a tumour. Instead, cancer develops through a slow, multi-step process with detectable warning ...